New-ATE-Logo2019 (1)

 

Linking mAb Product Quality

Profile Changes to Your Bioprocess:

Case Study of Dynamic Glucose Level Control

in CHO Process Improves Product Quality

 

Presenters:

 

11-19-2024-908-ATE-Speaker-1-HS-CroppedErin Redman, PhD
principal scientist,
908 Devices
 

Erin is a principal scientist in the research and development division of 908 Devices. She joined the company in 2016 and has worked to push the boundaries of the ZipChip technology for protein characterization. Prior to starting her career at 908 Devices, she received her doctoral degree under the direction of Professor J. Michael Ramsey at the University of North Carolina at Chapel Hill. There, she developed microfluidic technology for interfacing high resolution separations with electrospray mass spectrometry.

 

02-27-2024-908-Devices-ATE-Piras-HS-CroppedGraziella Piras, PhD
senior director of strategic marketing, life science,
908 Devices
 
 
Graziella has over 20 years of experience in developing applications and solutions for upstream bioprocessing. Before joining 908 Devices, she held various positions in marketing and R&D at Thermo Fisher Scientific, leading projects to support the cell culture and cell therapy business. Graziella obtained her PhD in biochemistry & molecular biology from the University of Liège in Belgium. She did her postdoc studying the role of epigenetic regulation on cancer and development at the National Cancer Institutes in Maryland.